Target intelligence / Profile preview

Daboia russelii siamensis C-type lectin-like venom protein (Snaclec)

Target
Snaclec
Molecular classification
C-type lectin-like protein, Venom toxin, Snaclec family
01

Overview

C-type lectin-like proteins (Snaclecs) from the venom of Daboia russelii siamensis (Eastern Russell's Viper) are non-enzymatic proteins that play a critical role in the pathophysiology of envenomation (PMID: 24530531). These proteins typically exist as heterodimers and exert their effects by binding with high affinity to various components of the hemostatic system, including platelet receptors like Glycoprotein Ib (GPIb) and Glycoprotein VI (GPVI), as well as blood coagulation factors such as Factor X and Factor IX (UniProt: P0C6S0). Depending on their specific structure, they can either induce or inhibit platelet aggregation and interfere with the coagulation cascade, leading to clinical manifestations such as systemic bleeding, consumption coagulopathy, and thrombocytopenia (PMID: 15533511). In a therapeutic context, these proteins are the primary targets for neutralization by monovalent or polyvalent antivenoms, which utilize purified antibodies to sequester the toxins and prevent their binding to physiological targets (WHO Guidelines on Snake Antivenoms). Beyond envenomation, Snaclecs are also studied as molecular tools for understanding vascular biology and as templates for developing novel antithrombotic agents (PMID: 18619475).

Other names
Snake venom C-type lectin-like proteinSnaclecCTLPsRussell's viper C-type lectin
02

Mechanism of action

Antivenom-mediated neutralization involves the binding of specific F(ab')2 or IgG antibodies to the toxin's functional sites, preventing the toxin from interacting with host platelet receptors or coagulation factors (PMID: 24530531).

03

Biological functions

Platelet aggregation modulation (PMID: 24530531)Blood coagulation regulation (UniProt: P0C6S0)Binding to Glycoprotein Ib (GPIb)Binding to Coagulation Factor XBinding to Coagulation Factor IX
04

Disease associations

Snakebite envenomationCoagulopathyThrombocytopeniaHemorrhage
05

Safety considerations

Anaphylaxis to antivenomSerum sicknessVenom recurrence
06

Interacting drugs

Daboia russelii siamensis Monovalent Antivenom

1 more in the full profile.

07

Biomarkers

Platelet countProthrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levels

Beyond the preview

Go deeper on Daboia russelii siamensis C-type lectin-like venom protein (Snaclec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia russelii siamensis C-type lectin-like venom protein (Snaclec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call